NOTV Stock Overview
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries.
Notes are coming soon
Inotiv, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$7.25|
|52 Week High||US$42.63|
|52 Week Low||US$3.65|
|1 Month Change||46.76%|
|3 Month Change||-60.38%|
|1 Year Change||-78.18%|
|3 Year Change||46.17%|
|5 Year Change||269.90%|
|Change since IPO||-12.12%|
Recent News & Updates
We Think Inotiv (NASDAQ:NOTV) Has A Fair Chunk Of DebtDec 08
Calculating The Intrinsic Value Of Inotiv, Inc. (NASDAQ:NOTV)Nov 17
Does Inotiv (NASDAQ:NOTV) Have A Healthy Balance Sheet?Sep 02
One Analyst's Revenue Estimates For Inotiv, Inc. (NASDAQ:NOTV) Are Surging HigherMay 04
Insider Buying: The Bioanalytical Systems, Inc. (NASDAQ:BASI) President Just Bought 2.2% More SharesFeb 25
Market Sentiment Around Loss-Making Bioanalytical Systems, Inc. (NASDAQ:BASI)Feb 09
The Bioanalytical Systems (NASDAQ:BASI) Share Price Has Soared 913%, Delighting Many ShareholdersJan 19
Here's What Bioanalytical Systems, Inc.'s (NASDAQ:BASI) Shareholder Ownership Structure Looks LikeDec 25
How Much Are Bioanalytical Systems, Inc. (NASDAQ:BASI) Insiders Spending On Buying Shares?Dec 04
|NOTV||US Life Sciences||US Market|
Return vs Industry: NOTV underperformed the US Life Sciences industry which returned -14.5% over the past year.
Return vs Market: NOTV underperformed the US Market which returned -13.6% over the past year.
|NOTV Average Weekly Movement||25.8%|
|Life Sciences Industry Average Movement||11.7%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||17.3%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: NOTV is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 26% a week.
Volatility Over Time: NOTV's weekly volatility has increased from 18% to 26% over the past year.
About the Company
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company’s BASi product line.
Inotiv, Inc. Fundamentals Summary
|NOTV fundamental statistics|
Is NOTV overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NOTV income statement (TTM)|
|Cost of Revenue||US$390.44m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-13.15|
|Net Profit Margin||-61.54%|
How did NOTV perform over the long term?See historical performance and comparison